The Food and Drug Administration (FDA) has accepted for Priority Review the New Drug Application for SL1009 (sodium dichloroacetate oral solution) for the treatment of pyruvate dehydrogenase complex ...

HighlightsTopline data for ATH434-201 randomized, double-blind Phase 2 clinical trial on track for expected release by early February ...

Researchers have made more advancements in multiple sclerosis in the last five years than in the previous 70 years. Knowing ...

Maharashtra’s health minister, Prakash Abitkar, during a visit to Pune a few days ago, says that the recent GBS outbreak in the city was most likely due to contaminated water sources.

Delve into the increasingly dynamic landscape of ALS treatment development with thirteen companies advancing candidates in ...

Read more about evidence based treatments that can help you reduce your alcohol use, particularly if you are finding it ...

A ketamine-based nasal spray is officially the first and only standalone therapy available for treatment-resistant depression ...

A recent clinical trial found that combining the oral medication baricitinib with narrowband UV-B light therapy significantly ...

Wehrli and her colleagues sought to explore whether a single oral dose of doxycycline ... and memory consolidation. The treatment very slightly reduced motor learning but subtly strengthened ...

Vigil posted positive phase 1 results for VG-3927, but competitor Alector's failure raises concerns about phase 2. Click here ...

Getting too cold can kill you. Here’s what you can do to prevent that from happening, and how to rescue yourself if it does.

Turmeric's active compound, curcumin, is a potent anti-inflammatory and antioxidant that can help with conditions like ...